Serum M2BPGi level and risk of hepatocellular carcinoma after oral anti-viral therapy in patients with chronic hepatitis B

2018 ◽  
Vol 48 (10) ◽  
pp. 1128-1137 ◽  
Author(s):  
Yao-Chun Hsu ◽  
Tomi Jun ◽  
Yen-Tsung Huang ◽  
Ming-Lun Yeh ◽  
Chia-Long Lee ◽  
...  
Keyword(s):  
Hepatocellular Carcinoma ◽  
Chronic Hepatitis ◽  
Hepatitis B ◽  
Chronic Hepatitis B ◽  
Viral Therapy ◽  
Anti Viral Therapy

scholarly journals Expression of cyclooxygenase-2 in chronic hepatitis B and the effects of anti-viral therapy

2002 ◽  
Vol 16 (2) ◽  
pp. 251-260 ◽  
Author(s):  
A. S. L. Cheng ◽  
H. L. Y. Chan ◽  
N. W. Y. Leung ◽  
C. T. Liew ◽  
K. F. To ◽  
...  
Keyword(s):  
Chronic Hepatitis ◽  
Hepatitis B ◽  
Chronic Hepatitis B ◽  
Cyclooxygenase 2 ◽  
Viral Therapy ◽  
Anti Viral Therapy

scholarly journals Predictors of relapse in chronic hepatitis B after discontinuation of anti-viral therapy

2011 ◽  
Vol 34 (3) ◽  
pp. 344-352 ◽  
Author(s):  
Y. Liang ◽  
J. Jiang ◽  
M. Su ◽  
Z. Liu ◽  
W. Guo ◽  
...  
Keyword(s):  
Chronic Hepatitis ◽  
Hepatitis B ◽  
Chronic Hepatitis B ◽  
Viral Therapy ◽  
Anti Viral Therapy
Sign in / Sign up

Export Citation Format

Share Document